SRSF3, as a splicing factor, is responsible for 23% of alternative RNA splicing events identified in 682 invasive breast ductal carcinoma patients and higher expression of SRSF3 was linked with shorter survival time and poorer prognosis (63). Here, SLU7 is linked to invasive ductal breast carcinoma.